Nova Patents
AT537190T

High affinity antibodies to human IL-6 receptor

Abstract

The application supplying a humanized antibody or antigen-binding sheet, comprising a human IL-6 receptor (hIL-6R) union's KD is from about 500pM or less, sealed with IL-6 activity IC50 is 200pM or less. The antibody or antibody sheet and hydrophilic hIL-6R of the ratio of the detecting IL-6R there is at least twice.

Term

0.7 yearsleft in the term

Expires 1 June 2027.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Expires

91 members in 38 offices

This recordMember, by publication datePriority claim28 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
81066406United States of AmericaP
84323206United States of AmericaP
2007013062United States of AmericaW

Members91

Family members, oldest first
DocumentOfficeKind
US2007280945A1United States of AmericaA1
AU2007254831A1AustraliaA1
CA2652976A1CanadaA1
WO2007143168A2World Intellectual Property Organization (WIPO)A2
WO2007143168A3World Intellectual Property Organization (WIPO)A3
MX2008014804AMexicoA
ECSP088993AEcuadorA
NO20085309LNorwayL
KR20090024690ARepublic of KoreaA
CR10462ACosta RicaA
EP2041177A2European Patent Office (EPO)A2
MA30535B1MoroccoB1
CN101454345AChinaA
GT200800272AGuatemalaA
US7582298B2United States of AmericaB2
SV2008003113AEl SalvadorA
JP2009539349AJapanA
ZA200809771BSouth AfricaB
TNSN08502A1TunisiaA1
RU2008152443ARussian FederationA
NZ573557ANew ZealandA
US2010316627A1United States of AmericaA1
US2010316636A1United States of AmericaA1
HN2008001792AHondurasA
IL195393D0IsraelD0
ME00519BMontenegroB
EP2374818A1European Patent Office (EPO)A1
US8043617B2United States of AmericaB2
RU2433138C2Russian FederationC2
EP2041177B1European Patent Office (EPO)B1
AT537190TThis recordAustriaT
US8080248B2United States of AmericaB2
US2012003697A1United States of AmericaA1
BRPI0712224A2BrazilA2
US2012045440A1United States of AmericaA1
DK2041177T3DenmarkT3
PT2041177EPortugalE
UA97645C2UkraineC2
AU2007254831B2AustraliaB2
ES2377579T3SpainT3
SI2041177T1SloveniaT1
HRP20120175T1CroatiaT1
US8183014B2United States of AmericaB2
NZ587107ANew ZealandA
US8192741B2United States of AmericaB2
CN102585002AChinaA
CN101454345BChinaB
RS52176BSerbiaB
PL2041177T3PolandT3
US2012258098A1United States of AmericaA1
MY147468AMalaysiaA
EP2374818B1European Patent Office (EPO)B1
DK2374818T3DenmarkT3
PT2374818EPortugalE
ES2398076T3SpainT3
SI2374818T1SloveniaT1
HRP20130228T1CroatiaT1
PL2374818T3PolandT3
US2013157313A1United States of AmericaA1
RS52643BSerbiaB
IL195393AIsraelA
JP5307708B2JapanB2
US8568721B2United States of AmericaB2
JP2013226143AJapanA
US2014255390A1United States of AmericaA1
US2014255995A1United States of AmericaA1
KR101464502B1Republic of KoreaB1
CA2652976CCanadaC
JP5805703B2JapanB2
CY1112456T1CyprusT1
JP2016026171AJapanA
US9308256B2United States of AmericaB2
CY1113708T1CyprusT1
US2016229916A1United States of AmericaA1
MY159787AMalaysiaA
JP6140777B2JapanB2
NO340778B1NorwayB1
NO2017060I1NorwayI1
LUC00050I1LuxembourgI1
LTPA2017038I1LithuaniaI1
HUS1700050I1HungaryI1
LUC00050I2LuxembourgI2
NL300911I2Netherlands (Kingdom of the)I2
US9884916B2United States of AmericaB2
LTC2041177I2LithuaniaI2
US2019256606A1United States of AmericaA1
US10584173B2United States of AmericaB2
BRPI0712224B1BrazilB1
US2021009698A1United States of AmericaA1
BRPI0712224B8BrazilB8
US11370843B2United States of AmericaB2